RBP4 and myeloid sarcoma: The association between plasma RBP4 levels and BMI, HOMA-IR, or other components of MS in obese patients is questioned by some researchers [15], while other researchers demonstrate correlation with BMI only in crude comparison and not in models adjusted for age and sex (for example: the Third Generation Framingham Heart Study cohort [28]).